Payment overview · 2025
General Payments
$160.26
3 reported records · 2 companies
Healthcare provider profile · identity verified
Stephen P Lang, MD
Allopathic & Osteopathic Physicians|Family Medicine · CARMEL, IN · NPI 1831270206
Verified facts
What the public records show
CMS Open Payments records show Stephen P Lang, MD received $160.26 in general payments during 2025 across 3 reported records.
Axsome Therapeutics, Inc. accounted for 77.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $124.73 | 77.8% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $35.53 | 22.2% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $160.26 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Symbravo Normalized: symbravo |
Drug | Axsome Therapeutics, Inc. | $124.73 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $35.53 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 608 | 182 |
| Atorvastatin Calcium | Atorvastatin Calcium | 594 | 171 |
| Amlodipine Besylate | Amlodipine Besylate | 478 | 144 |
| Losartan Potassium | Losartan Potassium | 366 | 105 |
| Levothyroxine Sodium | Levothyroxine Sodium | 352 | 92 |
| Hydrochlorothiazide | Hydrochlorothiazide | 320 | 96 |
| Metoprolol Succinate | Metoprolol Succinate | 281 | 86 |
| Lisinopril | Lisinopril | 197 | 64 |
| Tamsulosin Hcl | Tamsulosin Hcl | 179 | 61 |
| Omeprazole | Omeprazole | 173 | 55 |
| Simvastatin | Simvastatin | 162 | 49 |
| Metformin Hcl | Metformin Hcl | 146 | 46 |
| Gabapentin | Gabapentin | 142 | 53 |
| Finasteride | Finasteride | 134 | 38 |
| Zolpidem Tartrate | Zolpidem Tartrate | 133 | 41 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 129 | 35 |
| Allopurinol | Allopurinol | 119 | 33 |
| Doxazosin Mesylate | Doxazosin Mesylate | 107 | 31 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 106 | 30 |
| Alendronate Sodium | Alendronate Sodium | 105 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 95 | 30 |
| Clopidogrel | Clopidogrel Bisulfate | 93 | 27 |
| Ramipril | Ramipril | 91 | 24 |
| Ezetimibe | Ezetimibe | 89 | 31 |
| Trazodone Hcl | Trazodone Hcl | 89 | 34 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 88 | 29 |
| Metformin Hcl Er | Metformin Hcl | 88 | 26 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 85 | 26 |
| Meloxicam | Meloxicam | 84 | 32 |
| Tramadol Hcl | Tramadol Hcl | 84 | 18 |
| Potassium Chloride | Potassium Chloride | 82 | 27 |
| Irbesartan | Irbesartan | 80 | 24 |
| Pantoprazole Sodium | Pantoprazole Sodium | 77 | 27 |
| Montelukast Sodium | Montelukast Sodium | 75 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 74 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 73 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 72 | 22 |
| Spironolactone | Spironolactone | 71 | 22 |
| Ozempic | Semaglutide | 66 | 15 |
| Sertraline Hcl | Sertraline Hcl | 66 | 18 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 63 | 19 |
| Bupropion Xl | Bupropion Hcl | 62 | 21 |
| Jardiance | Empagliflozin | 61 | 21 |
| Clonazepam | Clonazepam | 59 | 15 |
| Atenolol | Atenolol | 58 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 57 | 20 |
| Furosemide | Furosemide | 57 | 21 |
| Celecoxib | Celecoxib | 55 | 15 |
| Benazepril Hcl | Benazepril Hcl | 53 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 53 | 25 |
| Synthroid | Levothyroxine Sodium | 52 | 13 |
| Alprazolam | Alprazolam | 51 | 26 |
| Eliquis | Apixaban | 51 | 19 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 51 | 14 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 48 | 22 |
| Carvedilol | Carvedilol | 48 | 16 |
| Clonidine Hcl | Clonidine Hcl | 47 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 46 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 45 | 16 |
| Lorazepam | Lorazepam | 44 | 17 |
| Glimepiride | Glimepiride | 43 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 42 | 15 |
| Pregabalin | Pregabalin | 42 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 41 | 11 |
| Prednisone | Prednisone | 39 | suppressed |
| Klor-Con M20 | Potassium Chloride | 38 | 16 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 34 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 33 | suppressed |
| Acyclovir | Acyclovir | 31 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 30 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 29 | 15 |
| Methylprednisolone | Methylprednisolone | 28 | 26 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 28 | 21 |
| Methylphenidate Hcl | Methylphenidate Hcl | 27 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 26 | suppressed |
| Lansoprazole | Lansoprazole | 26 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 26 | suppressed |
| Verapamil Er | Verapamil Hcl | 26 | suppressed |
| Xarelto | Rivaroxaban | 26 | suppressed |
| Famotidine | Famotidine | 25 | suppressed |
| Rybelsus | Semaglutide | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 24 | suppressed |
| Primidone | Primidone | 24 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 23 | suppressed |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 15 |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Fluconazole | Fluconazole | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 21 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 20 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 20 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 19 | suppressed |
| Chlorthalidone | Chlorthalidone | 19 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 19 | 16 |
| Mirtazapine | Mirtazapine | 18 | suppressed |
| Belsomra | Suvorexant | 17 | suppressed |
| Clonidine | Clonidine | 17 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Cephalexin | Cephalexin | 15 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 15 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 15 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 15 | 14 |
| Trulicity | Dulaglutide | 15 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Azithromycin | Azithromycin | 12 | 12 |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $160.26 · 3 records | Axsome Therapeutics, Inc. | Symbravo, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error